LORI THOMPSON: Open Payments
NPI 1316467749 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 14 payments from 9 companies in 2025. Trend: 2023 $1,158 · 2024 $904 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 1 | $100 |
| Vanda Pharmaceuticals Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Boston Scientific Corporation | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: VIVITROL, INGREZZA, REXULTI, HETLIOZ, TRINTELLIX, WaveWriter Alpha Prime 16, CAPLYTA, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
